AD Pharma

Global Nonalcoholic Steatohepatitis (NASH) Market 2017 (Weight Loss Treatment, Insulin-Sensitizing Agents, Lipid-Lowering Drugs, Antioxidants and Other Agents) and Forecast to 2022 : Global QYResearch

Press Release   •   Feb 16, 2017 12:01 EET

This report studies Global Nonalcoholic Steatohepatitis (NASH) Market 2017, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering

Boehringer Ingelheim?
Cerenis Therapeutics?
Connexios Life Sciences?
Genfit?
Islet Sciences?
Nimbus Therapeutics?
Verva Pharmaceuticals?
Viking Therapeutics?
Astazeneca Plc
Galmed Pharmaceuticals Ltd.
GENFIT SA
Gilead Science
Novo Nordisk
Immuron Ltd
Intercepts Pharmaceuticals
Enzo Biochem, Inc
Tobira Therapeutics, Inc.

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Nonalcoholic Steatohepatitis (NASH) in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India

Request more information at http://globalqyresearch.com/download-sample/165346 

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Weight Loss Treatment
Insulin-Sensitizing Agents
Lipid-Lowering Drugs
Antioxidants
Other Agents

Split by application, this report focuses on consumption, market share and growth rate of Nonalcoholic Steatohepatitis (NASH) in each application, can be divided into
Phase I
Phase II
Phase III
Clinical Trials

View full report at http://globalqyresearch.com/global-nonalcoholic-steatohepatitis-nash-market-research-report-2017

Table of Contents

Global Nonalcoholic Steatohepatitis (NASH) Market Research Report 2017
1 Nonalcoholic Steatohepatitis (NASH) Market Overview
1.1 Product Overview and Scope of Nonalcoholic Steatohepatitis (NASH)
1.2 Nonalcoholic Steatohepatitis (NASH) Segment by Type
1.2.1 Global Production Market Share of Nonalcoholic Steatohepatitis (NASH) by Type in 2015
1.2.2 Weight Loss Treatment
1.2.3 Insulin-Sensitizing Agents
1.2.4 Lipid-Lowering Drugs
1.2.5 Antioxidants
1.2.6 Other Agents
1.3 Nonalcoholic Steatohepatitis (NASH) Segment by Application
1.3.1 Nonalcoholic Steatohepatitis (NASH) Consumption Market Share by Application in 2015
1.3.2 Phase I
1.3.3 Phase II
1.3.4 Phase III
1.3.5 Clinical Trials
1.4 Nonalcoholic Steatohepatitis (NASH) Market by Region
1.4.1 North America Status and Prospect (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 China Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Nonalcoholic Steatohepatitis (NASH) (2012-2022)

2 Global Nonalcoholic Steatohepatitis (NASH) Market Competition by Manufacturers
2.1 Global Nonalcoholic Steatohepatitis (NASH) Production and Share by Manufacturers (2015 and 2016)
2.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Nonalcoholic Steatohepatitis (NASH) Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Nonalcoholic Steatohepatitis (NASH) Manufacturing Base Distribution, Sales Area and Product Type
2.5 Nonalcoholic Steatohepatitis (NASH) Market Competitive Situation and Trends
2.5.1 Nonalcoholic Steatohepatitis (NASH) Market Concentration Rate
2.5.2 Nonalcoholic Steatohepatitis (NASH) Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Nonalcoholic Steatohepatitis (NASH) Production, Revenue (Value) by Region (2012-2017)
3.1 Global Nonalcoholic Steatohepatitis (NASH) Production and Market Share by Region (2012-2017)
3.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue (Value) and Market Share by Region (2012-2017)
3.3 Global Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Price and Gross Margin (2012-2017)
3.4 North America Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Price and Gross Margin (2012-2017)
3.5 Europe Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Price and Gross Margin (2012-2017)
3.6 China Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Price and Gross Margin (2012-2017)
3.7 Japan Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Price and Gross Margin (2012-2017)
3.9 India Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Nonalcoholic Steatohepatitis (NASH) Supply (Production), Consumption, Export, Import by Regions (2012-2017)
4.1 Global Nonalcoholic Steatohepatitis (NASH) Consumption by Regions (2012-2017)
4.2 North America Nonalcoholic Steatohepatitis (NASH) Production, Consumption, Export, Import (2012-2017)
4.3 Europe Nonalcoholic Steatohepatitis (NASH) Production, Consumption, Export, Import (2012-2017)
4.4 China Nonalcoholic Steatohepatitis (NASH) Production, Consumption, Export, Import (2012-2017)
4.5 Japan Nonalcoholic Steatohepatitis (NASH) Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Production, Consumption, Export, Import (2012-2017)
4.7 India Nonalcoholic Steatohepatitis (NASH) Production, Consumption, Export, Import (2012-2017)

5 Global Nonalcoholic Steatohepatitis (NASH) Production, Revenue (Value), Price Trend by Type
5.1 Global Nonalcoholic Steatohepatitis (NASH) Production and Market Share by Type (2012-2017)
5.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue and Market Share by Type (2012-2017)
5.3 Global Nonalcoholic Steatohepatitis (NASH) Price by Type (2012-2017)
5.4 Global Nonalcoholic Steatohepatitis (NASH) Production Growth by Type (2012-2017)

6 Global Nonalcoholic Steatohepatitis (NASH) Market Analysis by Application
6.1 Global Nonalcoholic Steatohepatitis (NASH) Consumption and Market Share by Application (2012-2017)
6.2 Global Nonalcoholic Steatohepatitis (NASH) Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Nonalcoholic Steatohepatitis (NASH) Manufacturers Profiles/Analysis
7.1 Boehringer Ingelheim?
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Boehringer Ingelheim? Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 Cerenis Therapeutics?
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Cerenis Therapeutics? Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 Connexios Life Sciences?
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Connexios Life Sciences? Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 Genfit?
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Genfit? Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
7.5 Islet Sciences?
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
7.5.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Islet Sciences? Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5.4 Main Business/Business Overview
7.6 Nimbus Therapeutics?
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
7.6.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Nimbus Therapeutics? Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview
7.7 Verva Pharmaceuticals?
7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
7.7.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Verva Pharmaceuticals? Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Price and Gross Margin (2015 and 2016)
7.7.4 Main Business/Business Overview
7.8 Viking Therapeutics?
7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
7.8.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Viking Therapeutics? Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Price and Gross Margin (2015 and 2016)
7.8.4 Main Business/Business Overview
7.9 Astazeneca Plc
7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
7.9.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Astazeneca Plc Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Price and Gross Margin (2015 and 2016)
7.9.4 Main Business/Business Overview
7.10 Galmed Pharmaceuticals Ltd.
7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
7.10.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Galmed Pharmaceuticals Ltd. Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Price and Gross Margin (2015 and 2016)
7.10.4 Main Business/Business Overview
7.11 GENFIT SA
7.12 Gilead Science
7.13 Novo Nordisk
7.14 Immuron Ltd
7.15 Intercepts Pharmaceuticals
7.16 Enzo Biochem, Inc
7.17 Tobira Therapeutics, Inc.

8 Nonalcoholic Steatohepatitis (NASH) Manufacturing Cost Analysis
8.1 Nonalcoholic Steatohepatitis (NASH) Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Nonalcoholic Steatohepatitis (NASH)

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Nonalcoholic Steatohepatitis (NASH) Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Nonalcoholic Steatohepatitis (NASH) Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Nonalcoholic Steatohepatitis (NASH) Market Forecast (2017-2022)
12.1 Global Nonalcoholic Steatohepatitis (NASH) Production, Revenue and Price Forecast (2017-2022)
12.1.1 Global Nonalcoholic Steatohepatitis (NASH) Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Nonalcoholic Steatohepatitis (NASH) Price and Trend Forecast (2017-2022)
12.2 Global Nonalcoholic Steatohepatitis (NASH) Production, Consumption , Import and Export Forecast by Regions (2017-2022)
12.2.1 North America Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Nonalcoholic Steatohepatitis (NASH) Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Nonalcoholic Steatohepatitis (NASH) Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix

To Purchase this premium Report With Complete TOC at http://globalqyresearch.com/checkout-form/0/165346

About Us:

Global QYResearch (http://globalqyresearch.com/ ) is the one spot destination for all your research needs. Global QYResearch holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Contact Us:

Unit1, 26 Cleveland Road, South Woodford, London, E182AN, United Kingdom

Contact: +44 20 32392407

Email: sales@globalqyresearch.com

Follow us:https://www.linkedin.com/company/global-qy-research

Twitter: https://twitter.com/gqyresearch